Neuroprotection by caffeine and more specific A2A receptor antagonists in animal models of Parkinson's disease.

Source:http://linkedlifedata.com/resource/pubmed/id/14663012

Neurology 2003 Dec 9 61 11 Suppl 6 S55-61

Download in:

View as

General Info

PMID
14663012